levocetirizine dihydrochloride

Product NDC: 43598-735
Requested package NDC: 43598-735-97
11-digit product format: 435980735
Labeler code: 43598
Product ID: 43598-735_0b6d0486-2682-21fe-de0a-72d69a4b32c9
Type: HUMAN OTC DRUG
Nonproprietary name: levocetirizine dihydrochloride
Dosage form: TABLET, COATED
Route: ORAL
Labeler: Dr. Reddy's Laboratories Inc.
Application: ANDA210375
Marketing category: ANDA
Marketing start: 2018-03-12
Substance: LEVOCETIRIZINE DIHYDROCHLORIDE
Active strength: 5 mg/1
Pharmacologic classes: Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]
NDC exclude flag: No
Listing certified through: 2026-12-31
Current FDA listing: Yes

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 1 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
unfinished package	package	43598-735	43598-735-97	UNFINISHED	Active or certified unfinished drug listing		2026-08-17

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 16 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Snapshot, Source SHA-256 table
Captured / source date	Snapshot	Source SHA-256
2025-12-14 21:27 UTC · source 2025-12-05	`a6255e0c9aa5…`	`a0211a219f2e…`
2025-08-26 23:59 UTC · source 2025-08-26	`1d862106b807…`	`00c93037cd84…`
2025-05-15 14:59 UTC · source 2025-05-14	`390b4c401c3f…`	`2c692c2daee3…`
2025-04-01 07:37 UTC · source 2025-03-31	`e30019b0c005…`	`a3f0b14938b7…`
2025-03-01 13:19 UTC · source 2025-02-28	`bbbc9f937eca…`	`946b9c97cf81…`
2025-02-27 05:24 UTC · source 2025-02-26	`f268b84574a6…`	`26285f5ac5df…`
2025-02-01 13:13 UTC · source 2025-01-31	`f764e8902f78…`	`92046438deef…`
2025-01-20 13:05 UTC · source 2025-01-17	`68b1e3bced9e…`	`98a755eb8bc6…`
2024-11-29 20:42 UTC · source 2024-11-29	`05c55d027831…`	`ca05dca9dc4c…`
2024-11-09 02:36 UTC · source 2024-11-08	`48b4f40e6753…`	`c7c7a00d2afa…`
2024-10-09 02:27 UTC · source 2024-10-08	`27f29a85d7e4…`	`1372111e901f…`
2024-07-10 04:00 UTC · source 2024-07-09	`8d62ce987f31…`	`9fe9ef23e30d…`
2024-05-28 21:11 UTC · source 2024-05-28	`d1e113ab4d42…`	`063ee3eb0a1d…`
2024-05-15 03:51 UTC · source 2024-05-14	`50b4072663b7…`	`eae3003ed65e…`
2022-04-09 23:13 UTC · source 2022-04-08	`906f6e251498…`	`bf70b80e44f0…`
2021-12-27 23:28 UTC · source 2021-12-27	`6db9cb8d1e19…`	`3449e1ec5b70…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 42.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A210375-001	LEVOCETIRIZINE DIHYDROCHLORIDE	LEVOCETIRIZINE DIHYDROCHLORIDE	5MG	TABLET / ORAL			2018-01-19

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 42 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Approval date	Source SHA-256
2026-08-18 06:07:40	2026-07	A210375-001	LEVOCETIRIZINE DIHYDROCHLORIDE	5MG	TABLET / ORAL	2018-01-19	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A210375-001	LEVOCETIRIZINE DIHYDROCHLORIDE	5MG	TABLET / ORAL	2018-01-19	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A210375-001	LEVOCETIRIZINE DIHYDROCHLORIDE	5MG	TABLET / ORAL	2018-01-19	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A210375-001	LEVOCETIRIZINE DIHYDROCHLORIDE	5MG	TABLET / ORAL	2018-01-19	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A210375-001	LEVOCETIRIZINE DIHYDROCHLORIDE	5MG	TABLET / ORAL	2018-01-19	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A210375-001	LEVOCETIRIZINE DIHYDROCHLORIDE	5MG	TABLET / ORAL	2018-01-19	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A210375-001	LEVOCETIRIZINE DIHYDROCHLORIDE	5MG	TABLET / ORAL	2018-01-19	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A210375-001	LEVOCETIRIZINE DIHYDROCHLORIDE	5MG	TABLET / ORAL	2018-01-19	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A210375-001	LEVOCETIRIZINE DIHYDROCHLORIDE	5MG	TABLET / ORAL	2018-01-19	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A210375-001	LEVOCETIRIZINE DIHYDROCHLORIDE	5MG	TABLET / ORAL	2018-01-19	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A210375-001	LEVOCETIRIZINE DIHYDROCHLORIDE	5MG	TABLET / ORAL	2018-01-19	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A210375-001	LEVOCETIRIZINE DIHYDROCHLORIDE	5MG	TABLET / ORAL	2018-01-19	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A210375-001	LEVOCETIRIZINE DIHYDROCHLORIDE	5MG	TABLET / ORAL	2018-01-19	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A210375-001	LEVOCETIRIZINE DIHYDROCHLORIDE	5MG	TABLET / ORAL	2018-01-19	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A210375-001	LEVOCETIRIZINE DIHYDROCHLORIDE	5MG	TABLET / ORAL	2018-01-19	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A210375-001	LEVOCETIRIZINE DIHYDROCHLORIDE	5MG	TABLET / ORAL	2018-01-19	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A210375-001	LEVOCETIRIZINE DIHYDROCHLORIDE	5MG	TABLET / ORAL	2018-01-19	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A210375-001	LEVOCETIRIZINE DIHYDROCHLORIDE	5MG	TABLET / ORAL	2018-01-19	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A210375-001	LEVOCETIRIZINE DIHYDROCHLORIDE	5MG	TABLET / ORAL	2018-01-19	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A210375-001	LEVOCETIRIZINE DIHYDROCHLORIDE	5MG	TABLET / ORAL	2018-01-19	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A210375-001	LEVOCETIRIZINE DIHYDROCHLORIDE	5MG	TABLET / ORAL	2018-01-19	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A210375-001	LEVOCETIRIZINE DIHYDROCHLORIDE	5MG	TABLET / ORAL	2018-01-19	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	A210375-001	LEVOCETIRIZINE DIHYDROCHLORIDE	5MG	TABLET / ORAL	2018-01-19	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	A210375-001	LEVOCETIRIZINE DIHYDROCHLORIDE	5MG	TABLET / ORAL	2018-01-19	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	A210375-001	LEVOCETIRIZINE DIHYDROCHLORIDE	5MG	TABLET / ORAL	2018-01-19	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	A210375-001	LEVOCETIRIZINE DIHYDROCHLORIDE	5MG	TABLET / ORAL	2018-01-19	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	A210375-001	LEVOCETIRIZINE DIHYDROCHLORIDE	5MG	TABLET / ORAL	2018-01-19	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	A210375-001	LEVOCETIRIZINE DIHYDROCHLORIDE	5MG	TABLET / ORAL	2018-01-19	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	A210375-001	LEVOCETIRIZINE DIHYDROCHLORIDE	5MG	TABLET / ORAL	2018-01-19	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	A210375-001	LEVOCETIRIZINE DIHYDROCHLORIDE	5MG	TABLET / ORAL	2018-01-19	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	A210375-001	LEVOCETIRIZINE DIHYDROCHLORIDE	5MG	TABLET / ORAL	2018-01-19	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	A210375-001	LEVOCETIRIZINE DIHYDROCHLORIDE	5MG	TABLET / ORAL	2018-01-19	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	A210375-001	LEVOCETIRIZINE DIHYDROCHLORIDE	5MG	TABLET / ORAL	2018-01-19	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	A210375-001	LEVOCETIRIZINE DIHYDROCHLORIDE	5MG	TABLET / ORAL	2018-01-19	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	A210375-001	LEVOCETIRIZINE DIHYDROCHLORIDE	5MG	TABLET / ORAL	2018-01-19	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	A210375-001	LEVOCETIRIZINE DIHYDROCHLORIDE	5MG	TABLET / ORAL	2018-01-19	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	A210375-001	LEVOCETIRIZINE DIHYDROCHLORIDE	5MG	TABLET / ORAL	2018-01-19	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	A210375-001	LEVOCETIRIZINE DIHYDROCHLORIDE	5MG	TABLET / ORAL	2018-01-19	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	A210375-001	LEVOCETIRIZINE DIHYDROCHLORIDE	5MG	TABLET / ORAL	2018-01-19	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	A210375-001	LEVOCETIRIZINE DIHYDROCHLORIDE	5MG	TABLET / ORAL	2018-01-19	`e64feba35796…`

Additional Listing Data#

Finished product: Yes
Brand name base: levocetirizine dihydrochloride
Listing expiration: 2027-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
LEVOCETIRIZINE DIHYDROCHLORIDE	5 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
SOD6A38AGA	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
855172	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
1f722b84-08de-7e6a-41ac-2c9d9bb9fb43	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
36cf9111-9cc4-8f59-a74c-0c1cfbd4a760	Product name	7	20190702

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
43598-735-04	levocetirizine dihydrochloride	1 in 1 CARTON	TABLET, COATED	1	14
43598-735-04	levocetirizine dihydrochloride	120 in 1 BOTTLE	TABLET, COATED	120	14
43598-735-22	levocetirizine dihydrochloride	55 in 1 BOTTLE	TABLET, COATED	55	14
43598-735-22	levocetirizine dihydrochloride	1 in 1 CARTON	TABLET, COATED	1	14
43598-735-30	levocetirizine dihydrochloride	1 in 1 CARTON	TABLET, COATED	1	14
43598-735-30	levocetirizine dihydrochloride	30 in 1 BOTTLE	TABLET, COATED	30	14
43598-735-35	levocetirizine dihydrochloride	35 in 1 BOTTLE	TABLET, COATED	35	14
43598-735-35	levocetirizine dihydrochloride	1 in 1 CARTON	TABLET, COATED	1	14
43598-735-58	levocetirizine dihydrochloride	10 in 1 BOTTLE	TABLET, COATED	10	14
43598-735-58	levocetirizine dihydrochloride	1 in 1 CARTON	TABLET, COATED	1	14
43598-735-79	levocetirizine dihydrochloride	2 in 1 CARTON	TABLET, COATED	2	14
43598-735-79	levocetirizine dihydrochloride	5 in 1 BLISTER PACK	TABLET, COATED	5	14
43598-735-80	levocetirizine dihydrochloride	80 in 1 BOTTLE	TABLET, COATED	80	14
43598-735-80	levocetirizine dihydrochloride	1 in 1 CARTON	TABLET, COATED	1	14
43598-735-90	levocetirizine dihydrochloride	90 in 1 BOTTLE	TABLET, COATED	90	14
43598-735-90	levocetirizine dihydrochloride	1 in 1 CARTON	TABLET, COATED	1	14
43598-735-95	levocetirizine dihydrochloride	200 in 1 BOTTLE	TABLET, COATED	200	14
43598-735-95	levocetirizine dihydrochloride	2 in 1 CARTON	TABLET, COATED	2	14

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
43598-735-30	EA - Each	43598-735	f63cfcf2-4da8-499a-bfc3-df6f91d40e05	1	2024-09-09
43598-735-90	EA - Each	43598-735	9046de29-e000-4f9e-a13e-a7b3f0a92658	1	2024-09-09

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
43598-735	LEVOCETIRIZINE DIHYDROCHLORIDE TABLET, COATED [DR. REDDY'S LABORATORIES INC.]	13	Current NDC, Legacy NDC, 18 package rows	20240820_1f722b84-08de-7e6a-41ac-2c9d9bb9fb43.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 16 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
levocetirizine dihydrochloride	LEVOCETIRIZINE DIHYDROCHLORIDE	Dr. Reddy's Laboratories Inc.	1f722b84-08de-7e6a-41ac-2c9d9bb9fb43	2026-06-04	Warnings	Exact identifier application applno (ANDA): 210375 application number: ANDA210375 ndc (product): 43598-735
levocetirizine dihydrochloride	LEVOCETIRIZINE DIHYDROCHLORIDE	KROGER COMPANY	e47658af-e0f3-5765-f568-300ba407dc29	2026-01-20	Warnings	Exact identifier application applno (ANDA): 210375 application number: ANDA210375
levocetirizine dihydrochloride	LEVOCETIRIZINE DIHYDROCHLORIDE	CVS PHARMACY	c8681ca3-27b4-6738-af72-599ff05f2ec8	2026-01-20	Warnings	Exact identifier application applno (ANDA): 210375 application number: ANDA210375
levocetirizine dihydrochloride	LEVOCETIRIZINE DIHYDROCHLORIDE	Walgreens Company	766b8836-74b8-8af7-b900-b813b4fc175b	2026-01-20	Warnings	Exact identifier application applno (ANDA): 210375 application number: ANDA210375
24HR Allergy Relief	LEVOCETIRIZINE DIHYDROCHLORIDE	LEADER/ Cardinal Health 110, Inc.	6ba57f12-fd25-c4a6-ff2d-2955116f84c4	2026-01-20	Warnings	Exact identifier application applno (ANDA): 210375 application number: ANDA210375
Allergy Relief	LEVOCETIRIZINE DIHYDROCHLORIDE	Albertsons Companies	e1a6932b-d076-6573-5b88-7b06c3a91681	2026-01-20	Warnings	Exact identifier application applno (ANDA): 210375 application number: ANDA210375
levocetirizine dihydrochloride	LEVOCETIRIZINE DIHYDROCHLORIDE	SAM'S WEST INC	bb8d38b2-117a-fc6b-4ba0-0bc0188cbcd1	2026-01-19	Warnings	Exact identifier application applno (ANDA): 210375 application number: ANDA210375
levocetirizine dihydrochloride	LEVOCETIRIZINE DIHYDROCHLORIDE	Target Corporation	7e933c85-96b0-b103-e26a-1aa8a1ded58e	2026-01-19	Warnings	Exact identifier application applno (ANDA): 210375 application number: ANDA210375
levocetirizine dihydrochloride	LEVOCETIRIZINE DIHYDROCHLORIDE	HEB	b13ab6fc-4fec-c870-2c5f-b5e31dec722a	2026-01-19	Warnings	Exact identifier application applno (ANDA): 210375 application number: ANDA210375
levocetirizine dihydrochloride	LEVOCETIRIZINE DIHYDROCHLORIDE	Dr. Reddy's Laboratories Inc.	fb0a3619-9d5b-5c58-82f3-31f031672f33	2026-01-19	Warnings	Exact identifier application applno (ANDA): 210375 application number: ANDA210375
Levocetirizine Dihydrochloride	LEVOCETIRIZINE DIHYDROCHLORIDE	Walmart Inc.	82da5fa1-3633-2c48-32b9-d15482f308a1	2026-01-19	Warnings	Exact identifier application applno (ANDA): 210375 application number: ANDA210375
levocetirizine dihydrochloride	LEVOCETIRIZINE DIHYDROCHLORIDE	Rite Aid Corporation	fafc8149-d59a-1253-ae79-f33a088e3769	2025-12-10	Warnings	Exact identifier application applno (ANDA): 210375 application number: ANDA210375
levocetirizine dihydrochloride	LEVOCETIRIZINE DIHYDROCHLORIDE	BJWC (Berkley & Jensen / BJ'S)	0216f644-767c-ae88-f48f-cd29ac1547ed	2025-12-10	Warnings	Exact identifier application applno (ANDA): 210375 application number: ANDA210375
levocetirizine dihydrochloride	LEVOCETIRIZINE DIHYDROCHLORIDE	Chain Drug Marketing Association INC	61fb8bef-d868-adee-3237-d3268d603ba6	2025-12-10	Warnings	Exact identifier application applno (ANDA): 210375 application number: ANDA210375
Allergy Relief	LEVOCETIRIZINE DIHYDROCHLORIDE	AMERISOURCEBERGEN DRUG CORPORATION	fdf54de3-16a9-3b28-b4c4-d745322b3d3c	2025-12-10	Warnings	Exact identifier application applno (ANDA): 210375 application number: ANDA210375
levocetirizine dihydrochloride	LEVOCETIRIZINE DIHYDROCHLORIDE	United Natural Foods, Inc. dba UNFI	5036170d-7eeb-65a8-8473-7d98aeb51ee4	2025-12-10	Warnings	Exact identifier application applno (ANDA): 210375 application number: ANDA210375

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
SOD6A38AGA	LEVOCETIRIZINE DIHYDROCHLORIDE	130018-87-0	LEVOCETIRIZINE DIHYDROCHLORIDE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
855172	levocetirizine dihydrochloride 5 MG Oral Tablet	PSN	1f722b84-08de-7e6a-41ac-2c9d9bb9fb43	14
855172	levocetirizine dihydrochloride 5 MG Oral Tablet	SCD	1f722b84-08de-7e6a-41ac-2c9d9bb9fb43	14
855172	levocetirizine dihydrochloride 5 MG 24 HR Oral Tablet	SY	1f722b84-08de-7e6a-41ac-2c9d9bb9fb43	14
855172	levocetirizine dihydrochloride 5 MG Oral Tablet	PSN	c8681ca3-27b4-6738-af72-599ff05f2ec8	13
855172	levocetirizine dihydrochloride 5 MG Oral Tablet	SCD	c8681ca3-27b4-6738-af72-599ff05f2ec8	13
855172	levocetirizine dihydrochloride 5 MG 24 HR Oral Tablet	SY	c8681ca3-27b4-6738-af72-599ff05f2ec8	13
855172	levocetirizine dihydrochloride 5 MG Oral Tablet	PSN	766b8836-74b8-8af7-b900-b813b4fc175b	10
855172	levocetirizine dihydrochloride 5 MG Oral Tablet	SCD	766b8836-74b8-8af7-b900-b813b4fc175b	10
855172	levocetirizine dihydrochloride 5 MG 24 HR Oral Tablet	SY	766b8836-74b8-8af7-b900-b813b4fc175b	10
855172	levocetirizine dihydrochloride 5 MG Oral Tablet	PSN	6ba57f12-fd25-c4a6-ff2d-2955116f84c4	9
855172	levocetirizine dihydrochloride 5 MG Oral Tablet	PSN	7e933c85-96b0-b103-e26a-1aa8a1ded58e	9
855172	levocetirizine dihydrochloride 5 MG Oral Tablet	PSN	e1a6932b-d076-6573-5b88-7b06c3a91681	9
855172	levocetirizine dihydrochloride 5 MG Oral Tablet	SCD	6ba57f12-fd25-c4a6-ff2d-2955116f84c4	9
855172	levocetirizine dihydrochloride 5 MG Oral Tablet	SCD	e1a6932b-d076-6573-5b88-7b06c3a91681	9
855172	levocetirizine dihydrochloride 5 MG Oral Tablet	SCD	7e933c85-96b0-b103-e26a-1aa8a1ded58e	9
855172	levocetirizine dihydrochloride 5 MG 24 HR Oral Tablet	SY	6ba57f12-fd25-c4a6-ff2d-2955116f84c4	9
855172	levocetirizine dihydrochloride 5 MG 24 HR Oral Tablet	SY	e1a6932b-d076-6573-5b88-7b06c3a91681	9
855172	levocetirizine dihydrochloride 5 MG 24 HR Oral Tablet	SY	7e933c85-96b0-b103-e26a-1aa8a1ded58e	9
855172	levocetirizine dihydrochloride 5 MG Oral Tablet	PSN	82da5fa1-3633-2c48-32b9-d15482f308a1	8
855172	levocetirizine dihydrochloride 5 MG Oral Tablet	SCD	82da5fa1-3633-2c48-32b9-d15482f308a1	8
855172	levocetirizine dihydrochloride 5 MG 24 HR Oral Tablet	SY	82da5fa1-3633-2c48-32b9-d15482f308a1	8
855172	levocetirizine dihydrochloride 5 MG Oral Tablet	PSN	e47658af-e0f3-5765-f568-300ba407dc29	6
855172	levocetirizine dihydrochloride 5 MG Oral Tablet	PSN	b13ab6fc-4fec-c870-2c5f-b5e31dec722a	6
855172	levocetirizine dihydrochloride 5 MG Oral Tablet	SCD	e47658af-e0f3-5765-f568-300ba407dc29	6
855172	levocetirizine dihydrochloride 5 MG Oral Tablet	SCD	b13ab6fc-4fec-c870-2c5f-b5e31dec722a	6
855172	levocetirizine dihydrochloride 5 MG 24 HR Oral Tablet	SY	b13ab6fc-4fec-c870-2c5f-b5e31dec722a	6
855172	levocetirizine dihydrochloride 5 MG 24 HR Oral Tablet	SY	e47658af-e0f3-5765-f568-300ba407dc29	6
855172	levocetirizine dihydrochloride 5 MG Oral Tablet	PSN	fb0a3619-9d5b-5c58-82f3-31f031672f33	4
855172	levocetirizine dihydrochloride 5 MG Oral Tablet	PSN	bb8d38b2-117a-fc6b-4ba0-0bc0188cbcd1	4
855172	levocetirizine dihydrochloride 5 MG Oral Tablet	PSN	5036170d-7eeb-65a8-8473-7d98aeb51ee4	4
855172	levocetirizine dihydrochloride 5 MG Oral Tablet	SCD	bb8d38b2-117a-fc6b-4ba0-0bc0188cbcd1	4
855172	levocetirizine dihydrochloride 5 MG Oral Tablet	SCD	fb0a3619-9d5b-5c58-82f3-31f031672f33	4
855172	levocetirizine dihydrochloride 5 MG Oral Tablet	SCD	5036170d-7eeb-65a8-8473-7d98aeb51ee4	4
855172	levocetirizine dihydrochloride 5 MG 24 HR Oral Tablet	SY	5036170d-7eeb-65a8-8473-7d98aeb51ee4	4
855172	levocetirizine dihydrochloride 5 MG 24 HR Oral Tablet	SY	fb0a3619-9d5b-5c58-82f3-31f031672f33	4
855172	levocetirizine dihydrochloride 5 MG 24 HR Oral Tablet	SY	bb8d38b2-117a-fc6b-4ba0-0bc0188cbcd1	4
855172	levocetirizine dihydrochloride 5 MG Oral Tablet	PSN	61fb8bef-d868-adee-3237-d3268d603ba6	3
855172	levocetirizine dihydrochloride 5 MG Oral Tablet	PSN	0216f644-767c-ae88-f48f-cd29ac1547ed	3
855172	levocetirizine dihydrochloride 5 MG Oral Tablet	PSN	fafc8149-d59a-1253-ae79-f33a088e3769	3
855172	levocetirizine dihydrochloride 5 MG Oral Tablet	SCD	0216f644-767c-ae88-f48f-cd29ac1547ed	3
855172	levocetirizine dihydrochloride 5 MG Oral Tablet	SCD	fafc8149-d59a-1253-ae79-f33a088e3769	3
855172	levocetirizine dihydrochloride 5 MG Oral Tablet	SCD	61fb8bef-d868-adee-3237-d3268d603ba6	3
855172	levocetirizine dihydrochloride 5 MG 24 HR Oral Tablet	SY	fafc8149-d59a-1253-ae79-f33a088e3769	3
855172	levocetirizine dihydrochloride 5 MG 24 HR Oral Tablet	SY	61fb8bef-d868-adee-3237-d3268d603ba6	3
855172	levocetirizine dihydrochloride 5 MG 24 HR Oral Tablet	SY	0216f644-767c-ae88-f48f-cd29ac1547ed	3

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Marketing start	Status
43598-735-97	43598073597	10000 TABLET, COATED in 1 POUCH (43598-735-97)	10-MAR-18	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Levocetirzine Dihydrochloride Tablets USP, 5 mg	Dr. Reddy's Laboratories Inc. \| Dr.Reddy's Laboratories Limited-FTO 3 \| Reed-Lane, Inc.	2026-06-04	HUMAN OTC DRUG LABEL	15
Drug Facts	CVS PHARMACY	2026-01-20	HUMAN OTC DRUG LABEL	13
Drug Facts	Walgreens Company	2026-01-20	HUMAN OTC DRUG LABEL	10
Drug Facts	LEADER/ Cardinal Health 110, Inc.	2026-01-20	HUMAN OTC DRUG LABEL	9
Levocetirzine Dihydrochloride Tablets USP, 5 mg	Albertsons Companies	2026-01-20	HUMAN OTC DRUG LABEL	9
Drug Facts	KROGER COMPANY	2026-01-20	HUMAN OTC DRUG LABEL	6
Drug Facts	Target Corporation	2026-01-19	HUMAN OTC DRUG LABEL	9
Drug Facts	Walmart Inc.	2026-01-19	HUMAN OTC DRUG LABEL	8
Drug Facts	HEB	2026-01-19	HUMAN OTC DRUG LABEL	6
Levocetirzine Dihydrochloride Tablets USP, 5 mg	Dr. Reddy's Laboratories Inc. \| Dr.Reddy's Laboratories Limited-FTO 3 \| Reed-Lane, Inc.	2026-01-19	HUMAN OTC DRUG LABEL	4
Levocetirizine Dihydrochloride Tablets USP, 5 mg	SAM'S WEST INC	2026-01-19	HUMAN OTC DRUG LABEL	4
Drug Facts	United Natural Foods, Inc. dba UNFI	2025-12-10	HUMAN OTC DRUG LABEL	4
Levocetirizine Dihydrochloride Tablets USP, 5 mg	BJWC (Berkley & Jensen / BJ'S)	2025-12-10	HUMAN OTC DRUG LABEL	3
Levocetirzine Dihydrochloride Tablets USP, 5 mg	Chain Drug Marketing Association INC \| Dr.Reddy's Laboratories Limited-FTO 3 \| Reed-Lane, Inc.	2025-12-10	HUMAN OTC DRUG LABEL	3
Levocetirzine Dihydrochloride Tablets USP, 5 mg	Rite Aid Corporation \| Dr.Reddy's Laboratories Limited-FTO 3 \| Reed-Lane, Inc.	2025-12-10	HUMAN OTC DRUG LABEL	3